Gateway to the largest biotechnology sector in Australia

Find

Victorian Platform Technologies

Find Infrastructure

What's this

Victorian Biotech Companies & Providers

Advanced Search
What's this

Infrastructure

Victorian Platform Technologies Network

ARMI Zebrafish Core Facility

ARMI Zebrafish Core Facility

Platform technologies are a key driver of innovation and an area of significant infrastructure investment by the Victorian Government over the past ten years. Victoria is home to a comprehensive array of facilities such as the unique capabilities of the Australian Synchrotron, the Victorian Cancer Biobank, BioGrid Australia, and the Monash Antibody Technologies Facility.

The Victorian Platform Technologies Network (VPTN) improves awareness of, and access to, the varied platform technologies across Victoria and facilitates effective research-industry sector linkages.

The VPTN will comprise a number of geographical clusters (nodes), starting with the Bio21 Cluster node (based in the Central Precinct) and the Monash University node (based in the South Eastern Precinct). These nodes are connected by the BioPortal, as well as shared activities, such as workshops and skills development programs for facility managers.

You can search or browse platform technologies here and visit the VPTN website.

In addition to the VPTN there are other complimentary user group networks in Victoria such as Proteomics & Metabolomics Victoria and the Victorian Obesity Consortium and the Victorian Infection and Immunity Network. Please contact us if you want to list your network here.

What's Happening?

8th May BioBreakfast - The Technological and Economic Opportunities of BioBanking in Australia

Tuesday 8th May, 7:15am - 9:00am
Cinema 1, Australian Centre for the Moving Image (ACMI), Federation Square, Melbourne

As the pharmaceutical industry and the wider research sector shifts rapidly towards personalised medicine and genomics combined with the increasing power of computational sciences, biobanking is clearly an emerging winner in terms of commercialisation opportunity and provision of quality research services for the future.

More news and events